Genetic Analysis Firm Gets $77 Million to Fund Growth, Eyes IPO

Sophia Genetics can rapidly analyze patients’ genomes
Generation Investment Management leads latest funding round

Inside Driver Laboratory as Harvard Doctors Backed by Li Ka-shing Try a Fix For Cancer Care — Photographer: Sanjit Das/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Jeremy Kahn

January 4, 2019 at 8:13 AM UTC

This article is for subscribers only.

Sophia Genetics, which helps hospitals analyze genetic data, has raised $77 million in funding in a round led by Al Gore’s Generation Investment Management, which backs socially responsible companies.

The seven-year-old medical technology company, which was founded in Switzerland and has offices in Lausanne and Boston, uses machine learning to help doctors pinpoint mutations in genetic data and diagnose and treat cancer and hereditary conditions.